Metabolically associated fatty liver disease (MAFLD) is one of the most common chronic liver diseases, characterized by lipid accumulation and inflammation leading to steatohepatitis and fibrosis. The influence of hypobaric hypoxia, typical for high-altitude regions, on the pathogenesis of MAFLD remains poorly understood, despite its potential role in metabolic and inflammatory regulation. To investigate the features of the pathogenesis and course of MAFLD under hypobaric hypoxia using an experimental animal model. The study was conducted on 191 male rats weighing 150–250 g. MAFLD was induced by a fructose-fat diet (FFD) for 5 and 10 weeks. Experimental groups included lowland (Bishkek, 800 m) and hypobaric hypoxia (barochamber, 6000 m, 6 h/day). Biochemical parameters (ALT, AST, bilirubin, total protein, lipid profile, cytokines) and hepatic morphology were analyzed. Therapeutic interventions included normal diet, vitamin E, and metformin. FFD induced marked metabolic and morphological changes consistent with steatohepatitis. Under hypobaric hypoxia, rats exhibited significantly lower ALT and AST (p<0.001) and moderate hyperbilirubinemia, indicating hepatic hypoergy and adaptive cholestasis. Cytokine index (TNF-α/IL-4) suggested attenuated inflammation. Morphologically, hepatocyte and nuclear hypertrophy, ductular proliferation, and regenerative signs were observed. The combination of dietary normalization and vitamin E therapy produced the most significant improvement in biochemical and histological parameters. Hypobaric hypoxia modulates the course of MAFLD by reducing cytolytic and inflammatory activity while enhancing hepatic regeneration. These findings suggest that hypobaric hypoxia may serve as both a valuable experimental model and a potential adjunctive factor in the rehabilitation of patients with metabolic liver disease.